Center-Authored Papers

Filters: Author is Hesketh, Paul J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Vomiting
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Treatment Outcome
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Survival Rate
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Serotonin Antagonists
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Receptor, Epidermal Growth Factor
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Radiotherapy
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Quinuclidines
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Quinazolines
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Questionnaires
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Quality of Life
Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D.  2004.  Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 12(8):543-9. Abstract
Public Health Sciences Division
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Protein Kinase Inhibitors
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Prognosis
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Neurokinin-1 Receptor Antagonists
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Neoplasms
Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D.  2004.  Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 12(8):543-9. Abstract
Neoplasm Staging
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Nausea
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Morpholines
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Middle Aged
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Male
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Lung Neoplasms
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Isoquinolines
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Infusions, Intravenous
Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B et al..  2011.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(31):4189-98. Abstract
Humans
Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D.  2004.  Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 12(8):543-9. Abstract
Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract